GlassScriptPhysician profile
Michael Thomas Barkoukis
NPI 1740258128
$8,862.52
in general payments reported to CMS, 2019-2025
47 companies · $500 in 2025
The $500 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,946 · 2020: $780 · 2021: $722 · 2022: $699 · 2023: $528 · 2024: $689 · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,681 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,681.48 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Gpo, LLC | $3,695.11 | 2019 | |
| Astellas Pharma US INC | $916.38 | 2019-2025 | Xtandi |
| Neotract INC. | $441.15 | 2019-2020 | |
| Janssen Biotech, INC. | $392.78 | 2019-2024 | Erleada |
| Dendreon Pharmaceuticals LLC | $262.32 | 2019-2024 | Provenge |
| C. R. Bard, INC. & Subsidiaries | $237.30 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $200.40 | 2019-2022 | |
| Pfizer INC. | $176.41 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $166.64 | 2019-2024 | |
| Myovant Sciences INC. | $156.27 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $143.61 | 2019-2020 | |
| Urogen Pharma, INC. | $141.19 | 2021-2025 | |
| Procept Biorobotics Corporation | $110.50 | 2025 | |
| Blue Earth Diagnostics | $110.28 | 2021-2024 | |
| Progenics Pharmaceuticals, INC. | $106.50 | 2022-2025 | Pylarify |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $105.15 | 2023-2025 | Orgovyx, Gemtesa |
| Novartis Pharmaceuticals Corporation | $99.51 | 2022-2025 | |
| Abbvie INC. | $99.10 | 2020-2024 | Botox |
| Boston Scientific Corporation | $94.92 | 2019-2025 | Ams 700, Rezum Generator |
| Medtronic USA, INC. | $84.15 | 2019-2020 | |
| Teleflex LLC | $76.51 | 2021-2023 | Urolift |
| Coloplast Corp | $74.32 | 2019-2022 | |
| Verity Pharmaceuticals INC. | $73.23 | 2022-2024 | Trelstar |
| Allergan, INC. | $72.46 | 2020-2022 | |
| Amgen INC. | $72.40 | 2019-2021 | |
| Antares Pharma, INC. | $63.38 | 2019-2022 | |
| Abc Home Medical Supply, INC. | $63.10 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $62.07 | 2020-2025 | Imfinzi, Lynparza |
| Laborie Medical Technologies Corp. | $59.73 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Axonics, INC. | $59.16 | 2020-2023 | Bulkamid, Axonics |
| Tempus Ai, INC | $48.29 | 2024-2025 | Xt Cdx |
| Accord Healthcare, INC. | $40.34 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $35.46 | 2023-2024 | Yonsa |
| Urovant Sciences INC | $32.72 | 2022 | |
| Immunitybio, INC. | $29.59 | 2025 | |
| Calyxo, INC. | $29.47 | 2024-2025 | Cvac Aspiration System |
| Janssen Scientific Affairs, LLC | $28.94 | 2020 | |
| Olympus America INC. | $25.31 | 2022-2024 | Itind System |
| Clarus Therapeutics INC. | $25.12 | 2021 | |
| Telix Pharmaceuticals | $24.13 | 2024 | Illuccix |
| Bluewind Medical | $21.35 | 2024 | Revi |
| Tolmar, INC. | $20.55 | 2024 | |
| Medtronic, INC. | $19.66 | 2024 | Interstim |
| Myriad Genetic Laboratories, INC. | $19.07 | 2024 | Prolaris |
| Merck Sharp & Dohme LLC | $18.58 | 2023 | Lynparza, Keytruda |
| Koelis INC. | $14.75 | 2023 | |
| Photocure INC | $13.16 | 2023 | Cysview |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Barkoukis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.